Michele W.L. Teng

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

Jing Liu, Stephen J. Blake, Michelle C.R. Yong et al. · Cancer Discovery · 2016 · 833 citations

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald et al. · Nature Immunology · 2017 · 624 citations

Type 1, Cancer Immunosurveillance, Autoimmune Disease +12

Anti-TIM3 Antibody Promotes T Cell IFN-γ–Mediated Antitumor Immunity and Suppresses Established Tumors

Shin Foong Ngiow, Bianca von Scheidt, Hisaya Akiba et al. · Cancer Research · 2011 · 560 citations

TIGIT predominantly regulates the immune response via regulatory T cells

Sema Kurtuluş, Kaori Sakuishi, Shin-Foong Ngiow et al. · Journal of Clinical Investigation · 2015 · 534 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +20

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

John Stagg, Sherene Loi, Upulie Divisekera et al. · Proceedings of the National Academy of Sciences · 2011 · 476 citations